1-3% of pts.reportedblurred visionand eyeredness(Miebo)Installationsitereactions 8%(Vevye)Relief frominflammationin the first 15days(Vevye)MoneyBackGuarantee(Vevye)2ml in a5ml bottle(Vevye).09%Cyclosporine(Cequa)30 daysupply is 60.2ml vials(Xiidra).1%cyclosporine(Vevye).03mg ofvarenicline(Tyrvaya)95% of patientsexperienced noor mildinstallation sitepain (Cequa)When TYRVAYAhas not beenused for morethan 5 days, re-prime with 1spray into the air100%perfluorohexy-loctane(Miebo)Fre99.8% ofpatientsreported no ormildstinging/burning(Vevye)e!Lifitegrast5%(Xiidra)Calcineurininhibitorimmuno-suppressantopthalmicsolution (Cequa)Ocularburning17%(Restasis).05%Cyclosporine(Restasis)Availablefor $79(Vevye)82% ofpatientsreportedsneezing(Tyrvaya)30-daysupply is two4.2ml bottles(Tyrvaya)Improvementin cornealstaining afterjust 14 days(Cequa)65% of centralcorneas werecompletelyclear at 3months(Cequa)Improvementin SchirmerScore at day28(Tyrvaya)Patients stayon treatmentlonger thenRestasis andXiidra(Cequa)SymptomaticRelief in 2weeks in 2 outof 4 studies(Xiidra)The first andonly prescriptiondrop that directlytargets tearevaporationBlurred Visionwas the mostcommon ocularadversereaction(Miebo)one monthsupply is 60.25ml vials(Cequa)Reduces thesigns of dry eyeby week 12 insome patients(Xiidra)Improvementin visualacuity as earlyas day 56(Cequa)Increase inSchirmer scoreof 10mm overvehicle in 6 mo(Restasis)Throatirritation13% ofpatients(Tyrvaya)QID(Miebo)Wait 30minutes toinstill contactlenses(Miebo)Indicated forthe treatment ofthe signs &symptoms ofDED(M, V, T, X)SymptomImprovementin the first 30days(Vevye)1-3% of pts.reportedblurred visionand eyeredness(Miebo)Installationsitereactions 8%(Vevye)Relief frominflammationin the first 15days(Vevye)MoneyBackGuarantee(Vevye)2ml in a5ml bottle(Vevye).09%Cyclosporine(Cequa)30 daysupply is 60.2ml vials(Xiidra).1%cyclosporine(Vevye).03mg ofvarenicline(Tyrvaya)95% of patientsexperienced noor mildinstallation sitepain (Cequa)When TYRVAYAhas not beenused for morethan 5 days, re-prime with 1spray into the air100%perfluorohexy-loctane(Miebo)Fre99.8% ofpatientsreported no ormildstinging/burning(Vevye)e!Lifitegrast5%(Xiidra)Calcineurininhibitorimmuno-suppressantopthalmicsolution (Cequa)Ocularburning17%(Restasis).05%Cyclosporine(Restasis)Availablefor $79(Vevye)82% ofpatientsreportedsneezing(Tyrvaya)30-daysupply is two4.2ml bottles(Tyrvaya)Improvementin cornealstaining afterjust 14 days(Cequa)65% of centralcorneas werecompletelyclear at 3months(Cequa)Improvementin SchirmerScore at day28(Tyrvaya)Patients stayon treatmentlonger thenRestasis andXiidra(Cequa)SymptomaticRelief in 2weeks in 2 outof 4 studies(Xiidra)The first andonly prescriptiondrop that directlytargets tearevaporationBlurred Visionwas the mostcommon ocularadversereaction(Miebo)one monthsupply is 60.25ml vials(Cequa)Reduces thesigns of dry eyeby week 12 insome patients(Xiidra)Improvementin visualacuity as earlyas day 56(Cequa)Increase inSchirmer scoreof 10mm overvehicle in 6 mo(Restasis)Throatirritation13% ofpatients(Tyrvaya)QID(Miebo)Wait 30minutes toinstill contactlenses(Miebo)Indicated forthe treatment ofthe signs &symptoms ofDED(M, V, T, X)SymptomImprovementin the first 30days(Vevye)

Competitive Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
  1. 1-3% of pts. reported blurred vision and eye redness (Miebo)
  2. Installation site reactions 8% (Vevye)
  3. Relief from inflammation in the first 15 days (Vevye)
  4. Money Back Guarantee (Vevye)
  5. 2ml in a 5ml bottle (Vevye)
  6. .09% Cyclosporine (Cequa)
  7. 30 day supply is 60 .2ml vials (Xiidra)
  8. .1% cyclosporine (Vevye)
  9. .03mg of varenicline (Tyrvaya)
  10. 95% of patients experienced no or mild installation site pain (Cequa)
  11. When TYRVAYA has not been used for more than 5 days, re-prime with 1 spray into the air
  12. 100% perfluorohexy-loctane (Miebo)
  13. Fre99.8% of patients reported no or mild stinging/burning (Vevye)e!
  14. Lifitegrast 5% (Xiidra)
  15. Calcineurin inhibitor immuno-suppressant opthalmic solution (Cequa)
  16. Ocular burning 17% (Restasis)
  17. .05% Cyclosporine (Restasis)
  18. Available for $79 (Vevye)
  19. 82% of patients reported sneezing (Tyrvaya)
  20. 30-day supply is two 4.2ml bottles (Tyrvaya)
  21. Improvement in corneal staining after just 14 days (Cequa)
  22. 65% of central corneas were completely clear at 3 months (Cequa)
  23. Improvement in Schirmer Score at day 28 (Tyrvaya)
  24. Patients stay on treatment longer then Restasis and Xiidra (Cequa)
  25. Symptomatic Relief in 2 weeks in 2 out of 4 studies (Xiidra)
  26. The first and only prescription drop that directly targets tear evaporation
  27. Blurred Vision was the most common ocular adverse reaction (Miebo)
  28. one month supply is 60 .25ml vials (Cequa)
  29. Reduces the signs of dry eye by week 12 in some patients (Xiidra)
  30. Improvement in visual acuity as early as day 56 (Cequa)
  31. Increase in Schirmer score of 10mm over vehicle in 6 mo (Restasis)
  32. Throat irritation 13% of patients (Tyrvaya)
  33. QID (Miebo)
  34. Wait 30 minutes to instill contact lenses (Miebo)
  35. Indicated for the treatment of the signs & symptoms of DED (M, V, T, X)
  36. Symptom Improvement in the first 30 days (Vevye)